SINGAPORE CLINICAL RESEARCH INSTITUTE
πΈπ¬Singapore
- Country
- πΈπ¬Singapore
- Ownership
- -
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.scri.edu.sg/scri/
Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers
Phase 1
- Conditions
- Interventions
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Singapore Clinical Research Institute
- Target Recruit Count
- 24
- Registration Number
- NCT02140996
- Locations
- πΈπ¬
National Cancer Centre Singapore, Singapore, Singapore
πΈπ¬National Cancer Centre, Singapore, Singapore
The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM)
- First Posted Date
- 2012-01-18
- Last Posted Date
- 2016-01-06
- Lead Sponsor
- Singapore Clinical Research Institute
- Target Recruit Count
- 19
- Registration Number
- NCT01510847
- Locations
- πΈπ¬
EJ Tan Clinic & Surgery, Singapore, Singapore
πΈπ¬Bukit Batok Medical Clinic, Singapore, Singapore
πΈπ¬Frontier Medical Associates (Woodlands) Pte Ltd, Singapore, Singapore
Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2016-01-06
- Lead Sponsor
- Singapore Clinical Research Institute
- Target Recruit Count
- 35
- Registration Number
- NCT00712790
- Locations
- π°π·
Seoul National University Bundang Hospital, Seoul, Korea, Republic of
πΈπ¬Singapore General Hospital, Singapore, Singapore
πΈπ¬National Cancer Centre, Singapore, Singapore
Β© Copyright 2024. All Rights Reserved by MedPath